Objective—To determine duration of administration,
complications, and frequency of aortic thromboembolism
associated with administration of low molecular
weight heparin (dalteparin) in cats.
Animals—57 cats treated with dalteparin.
Procedure—Data were recorded from the medical
records of cats treated with dalteparin, and owners
were contacted by telephone for information regarding
ease of administration and possible adverse
Results—Dalteparin was easily administered by owners.
Median dose was 99 U/kg (45 U/lb) once or twice
daily. Bleeding complications were infrequent. Of 43
cats with cardiomyopathy that received owner-administered
dalteparin for a median follow-up time of 172
days, 8 cats developed documented or possible arterial
Conclusions and Clinical Relevance—Dalteparin
was easily administered by owners and was well tolerated
by cats. Whether dalteparin administration can
reduce the frequency or severity of arterial thromboembolism
is not yet known. (J Am Vet Med Assoc
Objective—To develop, validate, and evaluate a questionnaire (Cats’ Assessment Tool for Cardiac Health [CATCH] questionnaire) for assessing health-related quality of life in cats with cardiac disease.
Animals—275 cats with cardiac disease.
Procedures—The questionnaire was developed on the basis of clinical signs of cardiac disease in cats. A CATCH score was calculated by summing responses to questionnaire items; possible scores ranged from 0 to 80. For questionnaire validation, owners of 75 cats were asked to complete the questionnaire (10 owners completed the questionnaire twice). Disease severity was assessed with the International Small Animal Cardiac Health Council (ISACHC) classification for cardiac disease. Following validation, the final questionnaire was administered to owners of the remaining 200 cats.
Results—Internal consistency of the questionnaire was good, and the CATCH score was significantly correlated with ISACHC classification. For owners that completed the questionnaire twice, scores were significantly correlated. During the second phase of the study, the CATCH score ranged from 0 to 74 (median, 7) and was significantly correlated with ISACHC classification.
Conclusions and Clinical Relevance—Results suggested that the CATCH questionnaire is a valid and reliable method for assessing health-related quality of life in cats with cardiac disease. Further research is warranted to test the tool's sensitivity to changes in medical treatment and its potential role as a clinical and research tool.
Objective—To estimate disease prevalence among dogs and cats in the United States and Australia and proportions of dogs and cats that receive therapeutic diets or dietary supplements.
Sample Population—Dog and cat owners located in 5 geographic areas.
Procedures—A telephone survey was administered to dog and cat owners.
Results—Of 18,194 telephone calls that were made, 1,104 (6%) were to individuals who owned at least 1 dog or cat and agreed to participate. Information was collected for 635 dogs and 469 cats. Only 14 (1%) respondents indicated that their pet was unhealthy, but 176 (16%) indicated that their pets had 1 or more diseases. The most common diseases were musculo-skeletal, dental, and gastrointestinal tract or hepatic disease. Many owners (n = 356) reported their pets were overweight or obese, but only 3 reported obesity as a health problem in their pets. Owners of 28 (2.5%) animals reported that they were feeding a therapeutic diet, with the most common being diets for animals with renal disease (n = 5), reduced-calorie diets (5), and reduced-fat diets (4). Owners of 107 of 1,076 (9.9%) animals reported administering dietary supplements to their pets. Multivitamins (n = 53 animals), chondroprotective agents (22), and fatty acids (13) were the most common dietary supplements used.
Conclusions and Clinical Relevance—Results suggest that most dogs and cats reported by their owners to have a health problem were not being fed a therapeutic diet. In addition, the rate of dietary supplement use was lower than that reported for people.